Aspira Pathlab & Diagnostics Stock

Aspira Pathlab & Diagnostics Liabilities

The The Liabilities of Aspira Pathlab & Diagnostics (540788.BO) as of Aug 11, 2026 is 52.95 M INR. In the previous year, The Liabilities was 45.66 M INR — a change of 15.96% (higher).

Liabilities

52.95 MINR

YoY

15.96%

Last updated:

In 2026, Aspira Pathlab & Diagnostics's total liabilities amounted to 52.95 M INR, a 15.96% difference from the 45.66 M INR total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Aspira Pathlab & Diagnostics Stock analysis

What does Aspira Pathlab & Diagnostics do? Aspira Pathlab & Diagnostics is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Aspira Pathlab & Diagnostics's Liabilities

Aspira Pathlab & Diagnostics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Aspira Pathlab & Diagnostics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Aspira Pathlab & Diagnostics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Aspira Pathlab & Diagnostics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Aspira Pathlab & Diagnostics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Aspira Pathlab & Diagnostics stock

The Liabilities of Aspira Pathlab & Diagnostics is 52.95 M INR in 2026.

The Liabilities of Aspira Pathlab & Diagnostics changed from 45.66 M INR to 52.95 M INR, representing a 15.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Aspira Pathlab & Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Aspira Pathlab & Diagnostics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Aspira Pathlab & Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Aspira Pathlab & Diagnostics